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Oxytocin (OXT) and arginine-vasopressin (AVP) are two phylogenetically conserved
neuropeptides that have been implicated in a wide range of social behaviors. Although
a large body of research, ranging from rodents to humans, has reported on the effects
of OXT and AVP administration on affiliative and trust behaviors, and has highlighted the
genetic contributions of OXT and AVP receptor polymorphisms to both social behaviors
and to diseases related to social deficits, the consequences of peptide administration on
psychiatric symptoms, and the impact of receptor polymorphisms on receptor function,
are still unclear. Despite the exciting advances that these reports have brought to social
neuroscience, they remain preliminary and suffer from the problems that are inherent to
monogenetic linkage and association studies. As an alternative, some studies are using
polygenic approaches, and consider the contributions of other genes and pathways,
including those involving DA, 5-HT, and reelin, in addition to OXT and AVP; a handful of
report are also using genome-wide association studies. This review summarizes findings
on the associations between OXT and AVP receptor polymorphism, social behavior, and
psychiatric diseases. In addition, we discuss reports on the interactions of OXT and
AVP receptor genes and genes involved in other pathways (such as those of dopamine,
serotonin, and reelin), as well as research that has shed some light on the impact of gene
polymorphisms on the volume, connectivity, and activation of specific neural structures,
differential receptor expression, and plasma levels of the OXT and AVP peptides. We
hope that this effort will be helpful for understanding the studies performed so far, and
for encouraging the inclusion of other candidate genes not explored to date.
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INTRODUCTION
Today, the neuropeptides OXT and AVP are, perhaps, the
most interesting molecules for social neuroscience (Insel, 2010;
Meyer-Lindenberg et al., 2011; Zink and Meyer-Lindenberg,
2012). They are closely related, phylogenetically conserved
nonapeptides, which originated more than 700 million years
ago (Macdonald and Macdonald, 2010) and differ in only two
aminoacids (Caldwell et al., 2008; Insel, 2010; Macdonald and
Macdonald, 2010): whereas the aminoacid sequence of OXT
includes an isoleucine and a leucine at the third and eighth
position, respectively, AVP has a phenylalalanine and an arginine
in the corresponding positions (Figure 1). Both peptides contain
two cysteine residues that form a disulfide bond, creating a cyclic
six aminoacid ring (Caldwell et al., 2008).
OXT and AVP are synthesized in the somas of two groups
of neurons located in the paraventricular and supraoptic nucleus
of the hypothalamus (Figure 1); they are then transported along
axons that project to the posterior pituitary, from where they are
ultimately released into the circulation, acting as hormones on
peripheral targets (Loup et al., 1991; Meyer-Lindenberg et al.,
2011; Zink and Meyer-Lindenberg, 2012). In addition to their
well-documented peripheral actions (e.g., that of OXT in uterine
contraction and milk ejection, and of AVP in antidiuresis and
vasoconstriction; Loup et al., 1991) they also function within
the brain as neuromodulators or neurotransmitters. There they
act mainly via dendritic release (Landgraf and Neumann, 2004;
Ludwig and Leng, 2006; Leng and Ludwig, 2008; Neumann
and Landgraf, 2012; Stoop, 2012) to regulate complex social
cognition and behaviors, including attachment (Young et al.,
1999; Insel, 2010) and social exploration and recognition (Meyer-
Lindenberg et al., 2011). Furthermore, there is a growing body
of evidence showing that these neuropeptide signaling pathways
are impaired in mental disorders associated with social deficits
(Meyer-Lindenberg et al., 2011).
This review summarizes findings on the impact of different
OXT and AVP receptor polymorphism on social cognition
and behaviors, and on some of the most common mental
disorders associated with deficits in social function. Our goal
is to put special emphasis on the studies that have shed
light on associations involving different receptor polymorphism,
even if the functional significance of these polymorphisms is
currently unknown. In addition, we highlight the importance
of polygenic approaches for the fruitful understanding of the
OXT and AVP signaling mechanisms and the studies on the
effect of intranasal OXT and AVP infusions on psychiatric
disorders.
OXT AND AVP RECEPTORS AND THEIR
POLYMORPHISMS
OXT and AVP receptors (OXTR and AVPR, respectively) belong
to the seven transmembrane domain G-protein coupled receptor
super-family. Whereas only one form of OXTR is known, three
subtypes of AVPR exist, called AVPR1a, AVPR1b, and AVPR2
(Ebstein et al., 2012). The AVPR1a and AVPR1b subtypes are
both coupled to Gq, and signal via phospholipase C. The inositol
triphosphate (IP3) produced upon receptor activation induces
the mobilization of calcium (Ca2+) from intracellular reservoirs;
it also causes the release of diacylglycerol (DAG), which increases
intracellular Ca2+ and activates protein kinase C (PKC). The
rise in intracellular calcium levels activates map kinase (MAPK)
and calcium/calmodulin-dependent protein kinase II (CAMKII).
In addition, activation of this signaling pathway produces a
depolarization that leads to the entry of extracellular Ca2+ via
voltage-gated calcium channels (Thibonnier, 1992; Thibonnier
and Schork, 1995; Thibonnier et al., 2000). AVPR1a and AVPR1b
are expressed in several tissues and organs, including platelets,
the adrenal cortex, kidney, spleen, smooth muscle, endothelium,
and adipocytes (Thibonnier, 1992; Thibonnier and Schork, 1995;
Thibonnier et al., 2000). In the human brain, they are expressed
in the lateral septum, thalamus, basal amygdaloid nucleus, and
brainstem (Figure 2) but, interestingly, not in the cortex (Meyer-
Lindenberg et al., 2009). The AVPR2 subtype, on the other hand,
is coupled to Gs, which activates adenylyl cyclase (AC) and causes
the production of cAMP and the activation of protein kinase
A (PKA). This receptor subtype is expressed on the basolateral
membrane of the colleting duct in the medullary portion of
the kidney (Thibonnier et al., 2000). The single OXTR, on the
other hand, is coupled to Gq, activating the same intracellular
pathway as AVPR1a and AVPR1b. It is expressed in the uterus,
the mammary gland, the ovary, lactotroph cells and, in the
brain, in the central and basolateral amygdala, medial preoptic
area, anterior and ventromedial hypothalamus, olfactory nucleus,
vertical limb of the diagonal band of Broca, ventrolateral septum,
anterior cingulate, and hypoglossal and solitary nuclei (Figure 2;
Loup et al., 1991; Boccia et al., 2013). No expression has been
reported in the hippocampus (including CA2 and CA3), parietal
cortex, raphe nucleus, nucleus ambiguus or pons (Boccia et al.,
2013).
Interestingly, there is some evidence for the formation of
heterodimers between AVPR1a, AVPR2, and OXTR (Cottet
et al., 2010). Formation of such heteromeric receptors could
have important in vivo implications, and possibly confound
the interpretation of hormonal and neuromodulatory actions
(Devost and Zingg, 2003; Cottet et al., 2010). More importantly,
despite the highly conserved protein structure of the peptides
and of their receptors, it is noteworthy (particularly when
extrapolating to humans findings from research done on animals)
that their corresponding gene structure and spatial pattern of
expression presents species-specific variations, as shown, for
instance, in the sequence and brain expression of AVPR1a in
monogamous vs. non-monogamous vole species (Hammock and
Young, 2004, 2005). The variations in gene structure of OXTR
and AVPR mostly occur in the form of genetic polymorphisms,
which have been proposed to underlie inter- (Young et al.,
1999) and intraspecific (Young et al., 1999; Knafo et al., 2008)
differences in expression levels (Tansey et al., 2011) and spatial
expression patterns (Young et al., 1999; Knafo et al., 2008) in the
brain.
Types of Polymorphisms
A genetic polymorphism is the occurrence of two or more
genetic variants for a particular locus in the DNA sequence (i.e.,
Frontiers in Neuroscience | www.frontiersin.org 2 January 2016 | Volume 9 | Article 510
Aspé-Sánchez et al. OXTR and AVPR in Social and Psychiatric Traits
FIGURE 1 | OXT and AVP are two closely related nonapeptides that exert their action on central and peripheral targets. (A) OXT and AVP are synthesized
in the PVN and the SON of the hypothalamus. The peptidergic neurons in these nuclei project axons to the posterior pituitary, from where the peptides are released
into the circulation. They act as hormones on peripheral targets, having well-documented actions (uterine contraction and vasoconstriction, for instance). In addition,
dendrites of neurons in the PVN and the SON release the peptides directly into the brain, where they act as neurotransmitters or neuromodulators, regulating complex
social cognition and behaviors. (B) OXT and AVP differ in only two aminoacids: this schematic drawing shows that, whereas the aminoacid sequence of OXT (top)
includes an isoleucine at the third and a leucine at the eighth position, that of AVP (bottom) includes a phenylalanine and an arginine in the corresponding positions.
Both peptides contain a cyclic six aminoacid ring, because of the disulfide bond formed by two cysteine residues.
alleles) within a population. Polymorphisms can be classified
depending on the types of changes observed in the nucleotide
sequence. One of the most common is a change at the level
of single nucleotides (single nucleotide polymorphism, SNP).
SNP’s located in coding regions of the DNA can in turn be
classified as nonsynonymous and synonymous, depending on
whether or not they alter the amino-acid sequence of the
resulting protein, respectively. Finally, a non-synonymous SNP
can change the protein’s amino-acid sequence (i.e., missense
mutation) or result in a truncated protein (i.e., nonsense
mutation). SNPs located in noncoding regions can affect the
levels of expression and the spatial expression of a gene, and
can therefore also alter gene action (Plomin et al., 2008).
Several SNPs can occur simultaneously at different locations
within a given gene and tend to segregate together. Such
linked SNPs are called haplotype blocks, or simply haplotypes.
The occurrence of these blocks is useful for investigating the
genetic bases of common diseases, as it can reduce the number
of variants from 500,000 to around 350,000 (Plomin et al.,
2008).
Another common type of polymorphism is microsatellites, or
tandem simple sequences repeats (SSRs), which are sequences of
about 2–5 bp in length that are repeated, in tandem, between 5
and up to 50 times. In this case, alleles differ in the number of
SSR repeats that they contain. Despite the fact that most of the
microsatellites in the human genome are located in non-coding
regions, and are thus usually considered to be evolutionary
neutral, they can nevertheless cause phenotypic differences (Li
et al., 2004), including for neurological disorders in humans
(Amir et al., 1999).
INHERITANCE STUDIES ON HUMAN
BEHAVIOR
Studies on behavioral genetics have consistently shown that
heritability (the proportion of phenotypic variance attributable
to genotypic variance) plays a role in determining human
complex social traits. According to Plomin et al. (2008),
behaviors can depend on genotype in (at least) three ways:
(i) passively, where children inherit from their parents an
environment that is correlated with the children’s genetic
propensities; (ii) evocatively, where children evoke reactions
from other people on the basis of their genetic propensities,
and (iii) actively, by selecting, modifying, and constructing
experiences correlated with their genetic propensities. Thus,
a child inheriting a “depressive” allele could also inherit a
depressor environment from her depressive parents (passive); act
apathetically, making others avoid her (evocative); and develop
cognitive biases, viewing the life through gray glasses and
creating, in this way, her own depressing reality (active). These
genetic influences on environmental measures have been called
genotype-environment correlations (Plomin et al., 2008). In
addition, there exist genotype-environment interactions, where
the effect of environment on some traits depends on the genotype
and, conversely, the effect of a given genotype depends on
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FIGURE 2 | OXTR and AVPR are G-protein coupled receptor expressed in key structures of the brain. Their genes present characteristic polymorphisms
associated with differences in human social (and pathological) behaviors. (A) In the human brain, OXTR is expressed in the basolateral amygdala, the anterior and
ventromedial hypothalamus, the olfactory nucleus, the diagonal band of Broca, the septal nuclei and the anterior cingulate (left). Its gene (right) is located on
chromosome 3p25.3 (approximate position indicated by red vertical line). It contains four exons and three introns, which include several known SNPs. (B) AVPR1A is
expressed in the septal nuclei, the thalamus and the basal amygdaloid nucleus (left); the gene encoding this receptor (right) is located on chromosome 12q14
(approximate position indicated by red vertical line). As in the case for OXTR, it contains an intron before the exon that encodes the seventh transmembrane domain.
The schematic includes the SNPs (in the case of OXTR) and SSRs (in the case of AVPR) that are reviewed in this article.
the environment. Phenotypes are, in this way, more than the
sum of independent genetic and environmental factors: for
instance, variations in socially important behaviors are sensitive
to variations in genotypes (Plomin et al., 2008). The early
approaches that shed light on the genetic influences on human
social behavior, namely the linkage/association studies and the
quantitative traits loci (QTL) approach, are described below.
Linkage and Association Studies
In classical linkage studies, heritability is measured on the basis
of correlations found among relatives. These studies typically
analyze large pedigrees of families presenting a characteristic
trait, and, ideally, include monozygotic (MZ) and dizygotic
(DZ) twins. Because MZ twins have exactly the same genotype,
whereas DZ twins on average share only about 50% of their
genetic material, if genetic differences account for phenotypic
differences, thenMZ twins should exhibit higher correlation than
DZ twins in any particular trait (Cesarini et al., 2008; Plomin
et al., 2008). Furthermore, if MZ and DZ twins live in a shared
environment, then these correlations are useful for estimating
the relative influence of genetic vs. environmental factors on
phenotypic variation (Cesarini et al., 2008; Plomin et al., 2008).
A classical success story of this approach is in the analysis of
a five-generation pedigree of a family with members aﬄicted
by Huntington disease, which lead to the identification of the
CAG repeat associated with most cases of this disease (Walker,
2007; Plomin et al., 2008). Alternatively, sib-pair linkage analyses
can be carried out, in which case a small number of relatives is
considered, but in a large number of families. In both approaches,
the researcher is interested in looking for a marker that is co-
inherited with the trait of interest: however, these approaches
cannot detect associations in which genes have small effects, as
is the case for most complex behaviors or disorders (Risch, 2000;
Plomin et al., 2008). In addition, single-gene disorders tend to
be rare, whereas many important multifactorial traits or diseases,
including autism, depression, schizophrenia and others affecting
human social behavior, occur at much higher frequencies in the
population, and also show high heritabilities (Risch, 2000; Plomin
et al., 2008).
Association studies, rather than relying on the incidence of a
disease (and its associated markers) within families, test whether
the frequencies of specific alleles or genotypes differ between
groups such as affected individuals vs. controls, or among
individuals with extreme scores on a quantitative trait (Plomin
et al., 2008). These studies have classically been restricted to a few
“candidate” genes (see for instance, Knafo et al., 2008; Rodrigues
et al., 2009; Thompson et al., 2011; Luo et al., 2015a,b). The
influence of a given allele is then quantified, for instance, using
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the odds ratio, which is calculated as the ratio of the frequency
of an allele in affected individuals divided by the frequency of
this same allele in the control sample. By this measure, an odds
ratio of 1.0 means that there is no difference in allele frequencies
between affected individuals and controls, whereas odds ratios
larger than 3.0 is considered to represent a large effect (Plomin
et al., 2008; Brookfield, 2010).
Pitfalls of Linkage and Association Studies
In any association study, it is critical that the groups be well-
matched in terms of ethnicity, gender, and age (Plomin et al.,
2008; Brookfield, 2010). If not, the study could identify spurious
factors, which are simply due to differences between the groups
(Plomin et al., 2008; Brookfield, 2010). For instance, if a disease
is more prevalent in one of two ethnically different populations,
then any genetic variant that is more common in one of these
populations will show an association with a disease simply
because of differences in ethnicity. This could be the case for
some reports reviewed here, which show inconsistent results but
were based on different ethnics groups.
Quantitative Traits Loci (QTL)
In a classical monogenic approach, the presence or absence of a
trait follows a dichotomous distribution. In the case of qualitative
diseases (diseases where the trait is either present or not), a
single allele would be necessary and sufficient for the trait to
be expressed (Plomin et al., 2008; Brookfield, 2010). Currently,
around one thousand single-gene qualitative disorders are known
(Plomin et al., 2008). However, when the penetrance is very
low, it is virtually impossible to map genes using pedigrees
(Plomin et al., 2008; Brookfield, 2010); more importantly, most
human social and pathological behaviors are better described as a
quantitative and continuous, rather than as a discrete, qualitative
variable (Plomin et al., 2008). A polygene (or quantitative gene),
on the other hand, is a group of usually pleiotropic genes, which
together influence a phenotypic trait, leading to additive, non-
epistatic effects (Plomin et al., 2008; Brookfield, 2010). Thus,
a quantitative trait is a phenotype that varies in degree and
can be attributed to polygenic effects, i.e., the product of two
or more genes. Each gene is inherited in a Mendelian fashion,
but the additive effect of several genes results in phenotypes
that approach a normal distribution within the population
(Plomin et al., 2008; Brookfield, 2010). If we include into this
model the effects of the environment, then we are dealing with
multifactorial traits, where the presence or absence of a trait or
disease is influenced by many genetic differences as well as by
the environment (Plomin et al., 2008). This approach predicts
a continuum of genetic risk, in which diagnosed subjects could
be extreme cases that differ quantitatively, but not qualitatively,
from normal cases (Plomin et al., 2008).
ROLE OF OXTR AND AVPR IN SOCIAL
BEHAVIORS
Studies in Rodents
Reports implicating OXT and AVP in the control of mammalian
social behavior first appeared in the early 90’s. For instance, Insel
and Shapiro (1992) showed that the distribution of OXTR in
the brain of voles differed between monogamous (prairie) and
polygamous (montane) species. Likewise, AVPR distribution also
differed between these species, most likely because of differences
in promoter structure (SSRs polymorphisms; Young et al., 1999).
Most interestingly, intracerebroventricular injections of AVP
increased affiliative behaviors in the monogamous prairie vole,
but not in the promiscuous montane species (Young et al., 1999),
and transgenic mice expressing the prairie vole variant of AVPR
also showed increased affiliative behaviors in response to AVP
injections (Young et al., 1999). Collectively, these findings suggest
that the different pattern of AVPR expression is responsible for
the different affiliative behaviors of these two closely related
species of voles, as well as for their behavioral responses
to AVP.
Since these early studies, a large amount of research has been
carried out on these two so-called “prosocial neuropeptides,”
most of them using the powerful techniques available in rodent
models (Nakajima et al., 2014; Sala et al., 2015; Yan et al.,
2015). Regarding OXT, for instance, Nakajima et al. (2014)
demonstrated that blocking neurotransmission from medial
prefrontal cortex (mPFC) interneurons that express OXTR
(specifically, somatostatin neurons) caused female mice to lose
interest in male mice during the sexually receptive phase of the
estrous cycle (Nakajima et al., 2014). Similarly, behavioral despair
(a behavior associated with depression) was shown to enhance
OXT synthesis and secretion in the paraventricular nucleus,
supra-optic nucleus, frontal cortex, amygdala, and hippocampus,
as well as OXT release from the posterior pituitary into the
blood (Yan et al., 2015). Finally, and as a way of example, OXTR
null mice (OXTR −/−) display increased aggression and autistic-
like deficits in social behaviors, such as a resistance to changes
in a learned pattern of behavior (comparable to the restricted
interest and repetitive behaviors associated with autism; Sala
et al., 2015). Furthermore, this study suggests that intracerebral
administration of both OXT and AVP reverts the social and
learning defects by acting on AVPR1a receptors (Sala et al., 2015).
Insights have also been obtained into the possible functionality
of some of the AVPR alleles, including the impact of SSRs on
the pattern of AVPR expression in the brain (Young et al., 1999;
Hammock et al., 2005), transcriptional regulation (Hammock
and Young, 2004, 2005), and promotor activity (Tansey et al.,
2011), all of which are associated with differences in social
behaviors, including affiliation (Insel, 2010), aggression (Beery
et al., 2008), mating (Young et al., 1999; Caldwell et al., 2008),
and anxiety-like behaviors (Hammock et al., 2005; Neumann and
Landgraf, 2012).
Regarding psychiatric models, OXT administration has been
shown to mimic the effects of antipsychotic drugs. For example,
subcutaneous OXT administration in rats reduces prepulse
inhibition, a behavioral measure of sensorimotor gating in which
a startle response to a stimulus is reduced when it is preceded by a
weaker stimulus (Feifel and Reza, 1999; Feifel et al., 2012). These
results are relevant since prepulse inhibition is a neurological
phenomenon commonly seen in schizophrenic patients (Powell
et al., 2009; Ratajczak et al., 2013) thereby suggesting that OXT
could produce antipsychotic-like central effects.
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Notwithstanding the fact that results from rodents are not easy
to extrapolate to primates (for instance, Fink et al. (2006) found
that polymorphisms upstream of AVPR1a, which have been
associated with differences in social bonding, are evolutionarily
distinct between primates and rodents), a substantial body of
evidence obtained (initially) through linkage and association
studies suggests that OXTR and AVPR polymorphisms could be
part of the genetic sources of the heterogeneity observed in social
traits and psychiatric disorders (Meyer-Lindenberg et al., 2011).
The next sections describe the structure of the OXTR and AVPR
genes and summarize some of the monogenic studies supporting
the role of polymorphisms in these genes in human social and
pathological behavior.
Studies in Human
In humans, the 17Kb OXTR is located on chromosome 3p25.3
and contains four exons and three introns, one of them
containing more than twelve known SNPs (Inoue et al., 1994).
In the case of AVP, the genes encoding the 3 receptors (AVPR1a,
AVPR1b, and AVPR2) are located on chromosomes 12q14, 1q32,
and Xq28, respectively. As is the case for OXTR, all contain an
intron before the exon that encodes the seventh transmembrane
domain (Seibold et al., 1992; Sugimoto et al., 1994; Thibonnier
et al., 1996). The majority of polymorphisms studied in OXTR
gene are SNPs (Figure 2), and some of them appear to be
strongly associated with variability in social traits. One of the
most studied is rs53576, which consists of a G to A change within
the third intron of OXTR. In the case of AVPR1, the most studied
polymorphisms are SSRs, such as RS3 and RS1 (Figure 2), the
former located upstream of the transcription start site and the
latter located in a coding region 553 bp downstream from the
start site (Meyer-Lindenberg et al., 2011).
Monogenic Studies
In this section, we summarize the results from monogenetic
studies that have investigated the relationship between
polymorphisms in OXTR and AVPR and human social and
pathological behaviors. These analyses are summarized in
Table 1.
Prosocial behavior
An interesting line of research has shown that humans display
several “prosocial” behaviors, including trust, generosity and
altruism. These result are of great interest to fields such
as Neuroeconomics (Fehr and Camerer, 2007; Ebstein et al.,
2009), because the assumption of neoclassical economics is that
individuals always act to maximize a utility function which
depends exclusively on their own material gain (Fehr and
Schmidt, 1999). Because of a growing body of evidence that does
not support this hypothesis, this utility function has had to be
modified to include other-regarding preferences (Rabin, 1993;
Fehr and Schmidt, 1999; Dufwenberg and Kirchsteiger, 2004).
Two independent studies of monozygotic and dizygotic twins,
one in Sweden and one in the United States, have shown
that there is a significant heritability of prosocial behaviors.
Both studies were reported by Cesarini et al. (2008), who
estimated that correlations in trust behavior, as measured in a
classical Trust game, are 0.13 and 0.25 in the case of North
Americans and Swedish MZ twins, respectively, vs. 0.07 and
0.01 in both populations of DZ twins. The same applies for
trustworthiness: MZ were correlated in 0.26 (North Americans)
and 0.29 (Swedish), vs. 0.06 (North Americans) and 0.18
(Swedish) for DZ. The heritability estimate is 10% (with a 4–
21% confidence interval) for the U.S. study and 20% (with a 3–
38% confidence interval) for the Swedish study (Cesarini et al.,
2008). Interestingly, unshared environmental variation has a
greater impact on phenotypic variation than genetic variation. In
another study, the group of Cesarini found that strategies and
fundamental economic preference parameters are moderately
heritable, with estimates of heritability ranging from 18 to 42%
(Cesarini et al., 2009) and, importantly, has suggested that these
traits have a polygenic architecture, with the heritable variation
being explained bymany genes with small effects (Benjamin et al.,
2012).
Several association studies are also beginning to shed light on
the molecular basis of variations in these so-called “prosocial”
behaviors (Kosfeld et al., 2005; Zak et al., 2007; Israel et al., 2009;
Ebstein et al., 2010; Krueger et al., 2012; Radke and De Bruijn,
2012). In one of the first reports, Knafo et al. (2008) classified
theAVPR1a RS3 SSRs of participants into short (308–325 bp) and
long (327–343 bp) versions, and found, using the Dictator game,
that subjects with the short version allocated significantly fewer
tokens to others than did participants with the long versions. This
was confirmed and validated using the family-based association
test and two self-report scales (the Bardi-Schwartz Universalism
and Benevolence Value-expressive Behavior scales). Interestingly,
long AVPR1a RS3 repeats were associated with higher levels
of hippocampal AVPR1a mRNA levels in human post-mortem
studies, as compared to those measured in individuals bearing
the short RS3 repeats (Knafo et al., 2008). Along a similar line,
Krueger et al. (2012) reported that individuals homozygous for
the OXTR rs53576 G allele shows higher trust behavior (not
just a general increase in trustworthiness or risky behaviors)
than do A carriers (i.e., individuals presenting at least one A
allele in this SNP; Krueger et al., 2012). Similarly, OXT infusions
increase trust (Kosfeld et al., 2005), generosity (Zak et al., 2007),
and decrease adherence to social norms (Radke and De Bruijn,
2012).
In addition, AVPR1b alleles have been associated with
aggression levels in children. Luppino et al. (2014) reported a
significant relationship between the presence of the minor C
allele in SNP rs35369693 of AVPR1b and teacher-rated reactive
aggression (Luppino et al., 2014). Similarly, Zai et al. (2012)
found that this same SNP, as well as haplotypes containing
rs35369693 and rs28676508 (both in AVPR1b), were also
associated with higher child aggression (subjects that scored at
or above the 90th percentile on the aggression subscales of both
the Child Behavior Checklist and the Teacher’s Report Form; Zai
et al., 2012).
Empathy
Empathy is a social behavior defined as a capacity to share
and understand the feelings of others (De Vignemont and
Singer, 2006). Rodrigues et al. (2009) reported that subjects
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homozygous for the G allele of OXTR SNP rs53576 exhibit
greater empathy compared to A carriers, as measured by the
“Reading the Mind in the Eyes” task. Luo et al. (2015a)
compared the behavior and the fMRI responses of individuals
when they observed painful or non-painful stimulations of
other subjects, who were categorized by racial ingroup/outgroup
criteria. They found that individuals that were homozygous
for the G variant showed increased activity in the anterior
cingulate cortex (ACC) and supplementary motor area (SMA)
in response to racial ingroup members’ pain, as compared
to individuals homozygous for the A variant. By contrast,
individuals homozygous for the A allele showed increased
activity in structures of the reward system, specifically in
the nucleus accumbens, when they watched a racial outgroup
member in pain. This opposite response also predicts the
participants’ attitudes and behavior: the racial ingroup bias in
ACC/SMA activity was positively correlated with participants’
racial ingroup bias in implicit attitudes (specifically, they made
more associations between Asian vs. Caucasian faces and
concepts of “good” vs. “bad,” as measured by the Implicit
Association Test), whereas nucleus accumbens activity showed
a negative correlation with participants’ motivations to reduce
racial outgroup members’ pain.
Noticing the different results obtained between Eastern vs.
Western subjects in studies on empathy, this same group also
investigated whether the OXTR rs53576 SNP interacts with
the interdependence trait (i.e., how people view themselves in
relation to others) to modulate human empathy. They found a
stronger association between interdependence and empathy in
G carriers, as compared to A homozygotes (Luo et al., 2015b).
In addition, they used fMRI to measure the neural responses
elicited by the suffering of others, finding stronger associations
between interdependence and empathic neural responses in G/G,
as compared to A/A genotypes, in brain structures such as the
insula, amygdala, and the superior temporal gyrus Luo et al.
(2015b).
Other studies have investigated the association between other
common OXTR SNPs and empathy. Emotional empathy is
defined as the ability to respond with an appropriate emotion
to another’s mental states (De Waal, 2008; Shamay-Tsoory et al.,
2009). Wu et al. (2012) found an association between emotional
empathy and OTXR variation at the rs237887 SNP (with A allele
subjects scoring higher than those with the G allele), and the
rs4686302 SNP (with T allele subjects scoring higher than those
with the C allele). By contrast, cognitive empathy, the capacity
to understand another’s perspective or mental state (De Waal,
2008), showed associations with SNP polymorphisms rs2268491
(with carriers of the C/T variant scoring higher than those of the
C/C) and rs2254298 (with C/T carriers scoring higher than T/T
carriers; Wu et al., 2012).
Autism
Autism is a neurodevelopmental disorder characterized by
abnormalities in social relationships, communication deficits,
and restricted interests (Plomin et al., 2008), with a prevalence of
3–6 cases per 10,000 people. Its prevalence is four times higher
in males than in females (Freitag, 2007; Plomin et al., 2008).
Although the risk of autism in offspring of autistic parent(s)
is small (about 5%; Freitag, 2007; Plomin et al., 2008), it is,
nonetheless, 100 times greater than the rate of autism in the
general population (Freitag, 2007; Plomin et al., 2008).
A couple of studies have investigated the association between
SNPs rs53576, rs2268498, and autism, with rather confusing
results. In one of two family-based association tests (FBAT;
Horvath et al., 2001), Wu et al. (2005) found, in a study
involving Chinese Han individuals, a significant association
between autism and individual variants of OXTR SNPs rs53576
and rs2254298, as well as with haplotypes involving rs53576
(specifically, A-A-T-A in rs53576, rs2254298, rs2228485, and
rs237911, respectively). By contrast, Jacob et al. (2007), using
Caucasian individuals, found a significant association between
autism and polymorphism at the rs2254298 SNP, but not rs53576.
Moreover, they found that the overtransmission (i.e., a higher
likelihood that the risk allele is transmitted to the affected child, as
compared to the non-risk allele) of the G allele was more strongly
associated with the autistic disorder group, again in contrast to
the study involving Han patients (Wu et al., 2005), which, as
noted above, reported the overtransmission of the A allele (Jacob
et al., 2007). In addition, there are some reports associating the
short alleles of SSR RS1 inAVPRwith autism: Tansey et al. (2011),
for instance, found that the short alleles of RS1 show a weak
association with autism in an Irish population, consistent with
a previous study by Kim et al. (2002).
Schizophrenia
Schizophrenia is perhaps the most studied disorder of behavioral
genetic research in psychopathology (Plomin et al., 2008). Its
typical symptoms include delusions, hallucinations (especially
auditive), disorganization of speech and behavior, and negative
symptoms (i.e., loss of normal processes) like flat affect and
avolition (Gottesman, 1991; Plomin et al., 2008). It is estimated
that about 1% of the population is aﬄicted by the disorder,
which presents high heritability (about 48% in identical twins;
Gottesman, 1991; Plomin et al., 2008). Interestingly, although
it runs in families, the particular subtype (catatonic, paranoid,
disorganized) does not (Plomin et al., 2008).
There exists a small but significant association between
schizophrenia and polymorphisms in the Neuregulin I gene
(Lewis et al., 2003; Plomin et al., 2008), which is involved in the
development of the nervous system (Harrison and Law, 2006;
Plomin et al., 2008). Although there is currently no evidence
of an association between polymorphisms in OXTR and AVPR,
and schizophrenia, there are reports of associations between
OXTR and AVPR polymorphisms and traits associated with the
disease, such as attention (the main cognitive domain that is
impaired in this disorder; Powell et al., 2009; Ratajczak et al.,
2013) and negative symptomatology. Golimbet et al. (2015)
showed that the AVPR1A 327bp SSR in RS3 is associated with
negative symptoms (as measured using the Positive and Negative
Symptoms Scale, PNSS), and tended to be linked with patient
facial affect recognition, probably impacting social phenotypes
of schizophrenia. In addition, Levin et al. (2015) used a robust
family-based strategy to show that longer RS3 alleles were
associated with greater levels of prepulse inhibition, a classical
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paradigm designed to measure attention. This association was
stronger in males.
Depression
Depression is a state of low mood and aversion to activity,
with characteristic symptoms including anhedonia, overeating or
loss of appetite, insomnia, excessive sleep, fatigue, aches, pains,
digestive problems, and reduced energy (McGuffin et al., 2003;
Plomin et al., 2008). Subjects suffering severe depression may
contemplate, attempt to, or commit suicide (McGuffin and Katz,
1989; Plomin et al., 2008), emphasizing its societal importance.
The familial risk of major depression and of bipolar disorder
is about 9%, as compared to 3 and 1% in control samples for
depression and bipolar disorder, respectively (McGuffin et al.,
2003; Plomin et al., 2008).
Some reports have shown heritability of depression-protective
alleles and depression-related traits. Consistent with an
interpersonal perspective on depression (Joiner and Coyne,
1999), Apter-Levy et al. (2013) found that, in the families of
depressed mothers, salivary OXT levels was lower in mothers,
children and also in fathers, as compared to control families.
Children, in addition, had lower empathy and social engagement
levels, and 61% of the children displayed axis I disorders, mainly
anxiety and oppositional defiant disorder, compared to 15% of
children of nondepressed mothers. The OXTR rs2254298 SNP
homozygous for the G variant was overrepresented in depressed
mothers and their families (including fathers), and correlated
with lower salivary OXT. The presence of a single A allele in
this SNP in depressed mothers markedly decreased the risk
psychopathology in the child (Apter-Levy et al., 2013).
Another study found that youth possessing at least one A
allele of the OXTR rs53576 SNP, whose mothers had had a
history of depression (as measured at age 15, using the SCID-
I scale), exhibited the highest levels of depressive symptoms
at age 15 (as measured by the Beck Depression Inventory II;
BDI-II), showing that SNP rs53576 acts as a moderator variable
in the transmission of maternal depression from mothers to
their children (Thompson et al., 2014). In addition, under high
levels of childhood maltreatment (as reported by the Childhood
Maltreatment Questionnaire) only carriers of the G allele of
SNP rs53576 presented increased depressive symptomatology
(as measured by BDI) when compared to those with the A/A
genotype (McQuaid et al., 2013).Moreover, carriers of the G allele
were more emotionally sensitive (lower self-esteem) in response
to social ostracism (measured by the Social Ostracism and Mood
Scale), and showed altered blood pressure and cortisol levels
following social rejection induced by the Cyberball task, a well-
established computerized game used to induce feelings of social
rejection (Williams et al., 2000; McQuaid et al., 2015).
There are also reports on the putative role of polymorphisms
in AVPR genes and mood disorder spectrum (Dempster et al.,
2007). In a Swedish and a Belgian study, for instance, the
haplotype defined by alleles A-T-C-A-G for the AVPR1b SNPs
s1-s2-s3-s4-s5 was significantly over-represented in controls
vs. patients with depression (Van West et al., 2004). Despite
these associations, there are reports that, at least for OXTR,
polymorphisms do not alter antidepressant treatment resistance,
response or remission, nor are they associated with variations in
the inflammatory pathways that have been reported to play a role
in antidepressant efficacy, such as cyclooxygenase-2 and OXTR
SNPs rs53576 and rs2254298 (Mendlewicz et al., 2012).
Stress
Thompson et al. (2011) found, in a sample of Caucasian girls,
that subjects who were heterozygous for the OXTR rs2254298
polymorphism (presenting A–G substitutions), and had high
early life adversity, showed the highest levels of depression and
of physical and social anxiety. Another study showed influences
of the rs53576 SNP on stress: Thompson and Holman (2013),
for instance, found that individuals homozygous for the rs53576
G allele that had been exposed to a history of negative social
environment (specifically had been suffering high economic
stress, measured using a Likert scale created for the study)
showed elevated post-traumatic stress symptoms after the 9/11
events in the United States, as measured using the post-traumatic
stress disorder (PTSD) Checklist. The same risky G allele was
associated with lower cortisol responses to stress after social
support, compared to similarly challenged individuals of the
same genotype, but receiving no social support (Chen et al.,
2011). In addition, this G allele and the AVPR 320 bp RS1 SSR
seem to have a gender specific interaction with cortisol plasmatic
levels, where women, but notmen, with high levels of poststressor
OXT and the G/G genotype, felt the most positive affect after the
stressor; by contrast, only men with high levels of poststressor
AVP and the 320 allele of the RS1 polymorphism reported more
poststressor anger than noncarriers (Moons et al., 2014).
Harm avoidance
In females, the A/A genotype in rs53576 is associated with
an increase in harm avoidance. In addition, females with this
genotype presented significantly smaller amygdalar volumes,
bilaterally, especially its centromedial subregion. In addition, the
A/A allele is associated with reduced resting-state functional
bilateral coupling between the prefrontal cortex and amygdala:
in the left hemisphere this coupling was positively correlated with
harm avoidance scores in female subjects (Wang et al., 2014).
Neuroticism
Carriers of the G variant of rs53576 showed lower striatal
DAT availability and a negative correlation between DAT
availability and OXT levels (Chang et al., 2014). Furthermore,
the OXT× DAT interaction was significantly correlated with the
MPI neuroticism score in the A/A group (Chang et al., 2014).
Polygenic Approach
Do OXTR and AVPR signaling pathways interact with other
transmitter systems (Sauer et al., 2013)? This question has
recently been approached in studies involving both a couple of
well-known OXTR SNPs and AVPR SSRs, and polymorphisms in
genes from pathways known to interact with these neuropeptide
systems. A difficulty of this approach is that, mainly because of
pleiotropy, we often do not have a strong hypothesis regarding
which are relevant candidate genes and gene pathways to
consider (Plomin et al., 2008). For such cases, an increasingly
popular alternative is the genome-wide association studies
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(GWAS), which use a dense map of markers to genotype the
entire genome. This requires scanning about 500,000 SNPs or,
if selecting wisely based on haplotype blocks, about 350,000
SNPs (Cardon and Abecasis, 2003; Plomin et al., 2008); for
these purposes, a valuable complement is to use microarrays
(Plomin et al., 2008). However, given the limited accessibility to
GWAS (mainly due to their cost), and the lack of microarray
chips containing the OXTR and AVPR markers reviewed here
[for instance, the OXTR SNP rs53576 is not present on many
chips currently available for autism spectrum disorders (ASD);
Meyer-Lindenberg et al., 2011], selecting a couple of candidate
genes and studying their interactions via polygenic association
studies remains a valuable approach. In any event, there are
only a few reports that have used a candidate gene polygenic
approach or GWAS to investigate the effects (and functionality)
of polymorphisms in OXTR and AVPR on social and
pathological behaviors. These few (selected) studies are discussed
below.
Autism
Nyffeler et al. (2014) found, in a Caucasian population, that
a significant part of the risk for high functioning autism
is explained by the combination of four polymorphisms:
HTTLPR (a polymorphic repeat inside the gene coding for the
serotonin transporter), SNP rs6311 in HTR2A (which encodes
the serotonin receptor 5-HT2A), and the rs2254298 and rs53576
SNPs in the OXTR. These data provide evidence supporting a
polygenic inheritance of ASD, involving both the OXT and the
5-HT pathways (Nyffeler et al., 2014). Kelemenova et al. (2010),
using a sample of autistic boys in Slovakia, also focused their
research on several candidate gene polymorphisms associated
with autism, specifically OXT (rs2740204), OXTR (rs2228485),
GABA receptor gamma 3 (rs28431127), neuroligin (rs5916338),
and reelin. The authors found only one significant association:
between autism and a higher number of GGC repeats in the
(GGC)n STR polymorphism of the reelin gene, in addition to
finding lower reelin levels in the blood and the brain of autistic
patients.
Emotional withdrawal
Haram et al. (2015) performed an association analysis between
polymorphisms at four OXT pathway genes (OXT, OXTR,
AVP, and CD38) and four areas of social psychopathology (as
measured by Positive and Negative Syndrome Scale), finding
an association between the A allele in the rs53576 SNP and
the Emotional Withdrawal traits. However, they did not find an
association between any of the genes included in the analysis and
a diagnosis of psychotic disorder.
Oppositional-defiant disorder
In a GWAS performed in a clinical sample of children and
adolescents, Aebi et al. (2015) failed to find an association
between oppositional-defiant disorder and the polymorphisms
DRD4 exon3VNTR (located in exon 3 of the D4 dopamine
receptor gene), HTTLPR, and seven OXTR SNPs. They also
performed a GWAS including oppositional-defiant disorder
dimensions. Controlling for factors such as age, sex, and parental
abilities, the authors did not find an association between any of
the variables (Aebi et al., 2015).
What Do We Know about the Functional
Consequences of These Polymorphisms?
Amygdala volume
For OXTR rs2254298, participants homozygous for the G
allele were found to have smaller volumes of both left and
right amygdala, posterior brain stem and dorsomedial anterior
cingulate cortex, as compared to carriers of the A allele
(Furman et al., 2011). In this same SNP, the A allele was
positively correlated with bilateral amygdala volume: the larger
the number of rs2254298 A alleles an individual had, the
larger their amygdala volume. Furthermore, two three-single
nucleotide polymorphism haplotypes, including the rs2254298
G allele, showed significant associations with a smaller bilateral
amygdala volume (Inoue et al., 2010). These associations between
OXTR polymorphism and amygdala volume could provide
a hypothesis that explains how OXTR gene variants may
increase the risk of psychopathologies (Furman et al., 2011).
In addition, as stated above, the A/A genotype in rs53576 is
associated with significantly smaller bilateral amygdala volumes
and reduced resting-state bilateral coupling between amygdala
and the prefrontal cortex, specifically in women (Wang et al.,
2014).
Amygdala activation
Sauer et al. (2013), studying the interaction between OXT
plasma levels and the dopamine system, specifically the
common catechol-O-methyltransferase (COMT) val158met
polymorphism (a polymorphism known to influence COMT
activity and, consequently, dopamine degradation at synapses),
analyzed amygdala activation after the presentation of social
stimuli following placebo or OXT infusions. Their results showed
no gene main effect and no gene × substance interaction, but
a significant gene × gene × substance interaction. Indeed,
using various social stimuli paradigms, the authors found that,
when given placebo, the effect of CD38 on bilateral amygdala
activation was modulated by the COMT genotype; by contrast,
no such COMT genotype dependence was observed following
the administration of OXT (Sauer et al., 2013). These result are
consistent with the report of Baumgartner et al. (2008), who
found that intranasal infusions of OXT, in addition to making
subjects insensitive to unreciprocated trust (as measured with a
Trust game) show reduced activation of the amygdala and the
dorsal striatum when faced with social stimuli (specifically social
betrayal), as compared to a placebo group (see also Hurlemann
et al., 2010).
Regarding AVPR, Meyer-Lindenberg et al. (2009) showed that
two risky alleles in AVPR1A, the RS1 334 bp and the RS3 320 bp
alleles (which have been reported to have significant transmission
to autistic probands) are associated with opposing effects on
amygdala activation in an emotional face-matching task, a simple
perceptual task previously described to robustly engage the
amygdala. In this task, subjects must decide which one of two
faces is (emotionally) identical to a target face (Meyer-Lindenberg
et al., 2009). The authors found that the 334 bp RS1 allele was
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associated with stronger bilateral responses of the amygdala,
whereas the 320 bp RS3 carriers showed a smaller activation of
the left amygdala. However, there was no association between
these alleles and behavioral performance (Meyer-Lindenberg
et al., 2009).
Promoter activity
Both RS1 and RS3 showed differences in relative promoter
activity, as measured in the human neuroblastoma cell line
SH-SY5Y, with shorter repeat alleles of RS1 and RS3 showing
decreased relative promoter activity (Tansey et al., 2011).
Epigenetic effects
Recent findings by Reiner et al. (2015), in a sample of 43
clinically depressed and 42 healthy female subjects, suggest
epigenetic effects of the OXTR rs53576 genotype on the patterns
of methylation in exon 1 and 2 of OXTR. This OXTR SNP
moderated, for instance, the association between depression
and OXTR exon 1 methylation level. In this exon, a decreased
methylation state was associated with depression. This kind of
findings becomes more important now that strong evidence
suggests that specific genotypes show altered levels of DNA
methylation throughout the whole genome, depending on early
environment (Dadds et al., 2013; Chen et al., 2015).
Effects of Intranasal Administration of OXT
and AVP on Psychiatric Symptoms
The evidence on the effects of intranasal applications of OXT
and AVP on clinical populations expressing a mental disorder
is relatively sparse, and echoes the mixed findings for healthy
population. However, the use of intranasal OXT for the treatment
of psychiatric disorders shows some promise, particularly for
treating symptoms involving deficits in social functioning, such
as autism, schizophrenia, borderline personality, and social
anxiety disorders (Macdonald andMacdonald, 2010; MacDonald
et al., 2011; Anagnostou et al., 2012; Macdonald and Feifel, 2012;
Bakermans-Kranenburg and Van Ijzendoorn, 2013; Bethlehem
et al., 2013; De Berardis et al., 2013; Tachibana et al., 2013;
Veening and Olivier, 2013; Cardoso et al., 2014). For instance,
intranasal OXT has been shown to increase eye contact in
individuals with ASD, possibly by increasing the saliency of social
stimuli (Auyeung et al., 2015). Similarly, intranasal OXT, in ASD
patients, improves the ability to recognize the social emotions
of others, as measured both at the behavioral and neural levels
(Aoki et al., 2014). In addition, OXT may selectively affect the
salience and hedonic assessments of socially meaningful stimuli
in subjects with ASD, and thus help social attunement (Domes
et al., 2013; Gordon et al., 2013).
In individuals with Borderline Personality Disorder (BPD),
OXT administration has shown that the effects may differ
depending on baseline conditions, such as the participant’s
representations and expectations and/or an OXT system that is
not working properly. For instance, Bartz et al. (2011) tested
whether OXT administration improves trust and cooperative
behaviors in individuals with BPD vs. healthy controls, using the
Assurance Game (a variation of the Prisoner’s dilemma; Kreps
et al., 1982; Brosnan et al., 2011). They found that participants
with BPD expected their partners to be less cooperative after
administration of OXT, showing the opposite effect compared
to healthy controls, where OXT infusions increase trust
(Kosfeld et al., 2005; Bartz et al., 2011). In addition, intranasal
administration of OXT in schizophrenic populations has shown
an anxiolytic (Bell et al., 2006), antidepressant (Ozsoy et al.,
2009), and antipsychotic effect (Caldwell et al., 2009; Kuehn,
2011; Macdonald and Feifel, 2012; De Berardis et al., 2013).
Surprisingly, there is very limited evidence linking OXT
administration to social anxiety disorder (SAD). Guastella
et al. (2009) examined the effect of OXT administration as
an adjunct to therapy for SAD, finding that patients treated
with OXT showed significant differences in their ratings of
speech performance and speech appearance compared to patients
treated with placebo. Similarly, Labuschagne et al. (2010) showed,
using an emotional face matching paradigm as measure, that
intranasal OXT reduced amygdala reactivity to fearful faces in
participants diagnosed with SAD (Labuschagne et al., 2010).
In addition, the same group showed that intranasal OXT
administered to SAD participants reduced cortical hyperactivity
in the medial prefrontal cortex to sad faces to a level comparable
to that of controls. Taken together, these studies indicate that
OXT administration modulates the fear-related neural circuitry,
consistent with previous research showing pro-social effects of
OXT administration in healthy individuals.
Nevertheless, and as a cautionary note, a recent meta-
analysis examining the effect of intranasal OXT across various
clinical samples (i.e., ASD, social anxiety, depression, obsessive-
compulsive disorder, schizophrenia, borderline personality
disorder, and post-traumatic stress disorder) found only a
small to moderate effect on psychiatric symptomatology and
social competence indicators (Bakermans-Kranenburg and
Van Ijzendoorn, 2013). Moreover, Macdonald and Macdonald
(2010) suggested that the context-dependent and divergent
effects of OXT indicate that the effects of such OXT treatments
may depend on individual differences (i.e., modulation by sex,
hormonal and psychiatric status, and attachment style). The
available evidence reveals that chronic administration of OXT
causes mixed results, even within groups aﬄicted by the same
disorder (Tachibana et al., 2013; Dadds et al., 2014). In addition,
the effects of acute vs. chronic OXT administration have not been
thoroughly studied; thus, their relative merit for the treatment
of psychiatric disorders is unknown. Although promising, the
specific effects of OXT on psychiatric symptomatology remain
unclear.
Surprisingly, there is little research on the impact of intransal
AVP administration on psychiatric symptoms. Some studies
have suggested a link between AVP levels and psychiatric
disorders. For instance, cerebrospinal fluid AVP levels have
been positively correlated with a life history of interpersonal
aggression in individuals with personality disorders (Coccaro
et al., 1998). Similarly, Pitman et al. (1993) investigated the
effects of OXT and AVP on the emotional response of Vietnam
veterans with PTSD during personal combat imagery exercises.
Responses, measured by determining skin conductance, heart
rate, and electromyographic responses, showed that the group
that received AVP presented higher reactivity to combat imagery
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relative to the OXT and placebo groups, suggesting that AVP
may enhance the emotional valence of events (Coccaro et al.,
1998).
In healthy populations, intranasal AVP has been shown to also
improve social recognition. For example, Guastella et al. (2010a)
conducted a study where healthy males were asked to view faces
displaying happy, neutral, or angry expressions. Using a “surprise
memory test,” they showed that participants who received AVP
were more likely to remember happy and angry faces compared
to participants who received placebo (Guastella et al., 2010b).
These results suggest that AVP also enhances human recognition
of emotionally-valenced faces.
The very limited research using intranasal administration
of AVP (Coccaro et al., 1998; Guastella et al., 2010b) has,
nevertheless, revealed that this neuropeptide can exert important
effects on social information processing. The results discussed
above largely suggest that AVP may play a role in the processing
of emotionally-valenced information in both healthy and clinical
population.
DISCUSSION
A growing body of research has found associations between
alleles of OXTR and AVPR and human social and pathological
behavior, such as altruism (Knafo et al., 2008), generosity (Zak
et al., 2007) and aggression (Luppino et al., 2014); depression
(Van West et al., 2004; Apter-Levy et al., 2013; Thompson et al.,
2014), empathy (Wu et al., 2012; Luo et al., 2015a,b), autism (Wu
et al., 2005; Jacob et al., 2007; Kelemenova et al., 2010; Tansey
et al., 2011; Nyffeler et al., 2014), stress (Thompson et al., 2011;
Thompson and Holman, 2013), and schizophrenia (Golimbet
et al., 2015; Levin et al., 2015). However, these results remain
preliminary, and await further studies using other populations.
As a cautionary note, a recent meta-analysis performed by
Bakermans-Kranenburg and van Ijzendoorn (2014), found no
significant association between any of five outcomes (i.e., biology,
personality, social behavior, psychopathology, and autism) and
the SNPs rs53576 and rs2254298 (reviewed above), concluding
that these polymorphisms failed to explain a significant part of
human social behavioral diversity (Bakermans-Kranenburg and
van Ijzendoorn, 2014).
Functionality
A point to keep in mind is the old maxim “correlation does not
imply causation.” This means that a robust result associating,
for instance, a rs53576 polymorphism with a predisposition to
depression, does not imply that there exists a causal relationship
between the two variables. However, such an association does
have some inherent value: if we cannot find evidence showing
a causal relationship (or if this relationship does not exist at
all!), the data may still provide useful information, such as
pointing to a genetic region where the relevant gene is located
(Plomin et al., 2008). That correlation does not imply causation
also raises questions about the impact of polymorphisms on
gene function described in the literature. In other words, one
may ask: Do the OXTR’s SNPs and AVPR’s SSRs play a role in
causing the differences in phenotypic traits? Or, alternatively:
Do these variants lack functionality or do they just result from
“spurious” correlations? Yet, recent research is showing that these
polymorphisms are indeed associated with different volumes
of some neural structures (Inoue et al., 2010; Furman et al.,
2011), differential neuronal connectivity or activation (Meyer-
Lindenberg et al., 2009; Sauer et al., 2013); differential expression
of the receptors (Young et al., 1999; Knafo et al., 2008), plasmatic
levels of the peptides (Moons et al., 2014), or promotor activity
(Tansey et al., 2011). This suggests that neuropeptide receptor
polymorphisms likely do have a functional role in normal and
pathological human behavior. Anyway, there are also practical
benefits to identifying individuals at risk even without knowing
the mechanisms responsible for the deficit (Brookfield, 2010): for
instance, there are treatments and tests available that are offered
on the basis of calculated risk (Plomin et al., 2008; Brookfield,
2010).
Thinking about Normal and Psychopathic
Behavior as a Continuum
It is noteworthy that both the normal and pathological behaviors
covered in this review are most certainly quantitative traits,
involving interactions among more than one gene, and for
which the phenotypes of interest are better described as a
continuum. Consequently, the field needs to emphasize polygenic
association studies where, instead of a single gene underlying a
trait, there are multiple (functional) gene variants involved, each
making small quantitative contributions to the final phenotype
(Plomin et al., 2008; Brookfield, 2010). This notion (namely,
that many genes influence complex disorders or personality
traits) raises the question of why such disorders are typically
diagnosed as qualitative, and not as quantitative traits, with a
continuum of genetic risk. This quantitative approach allows one
to formulate two models: the liability threshold model, where
risk is distributed normally and disorders occur in a qualitative
fashion, when a threshold is exceeded (genetic continuum with
discrete phenotypes), vs. a model that proposes that phenotypes
change continuously from normal to abnormal, with diagnosed
cases being extreme cases that differ quantitatively, but not
qualitatively (Plomin et al., 2008). The latter seems to be the
best descriptor for depression and alcoholism, and even for
schizophrenia. It also allows finding genes that may be associated
with depression in aﬄicted patients and with mood changes in
normal patients.
Finally: What Do We Still Not Know?
GWAS promises to be a powerful tool for constructing the
complete landscape of interacting genes but, given its current
cost, have not replaced research that investigates candidate genes
in polygenic association studies. To date, in addition to OXTR
and AVPR SNPs and SSRs, polymorphisms in COMT, CD38,
HTTLPR, HTR2A and DAT are likely to be good candidates
for studying the genetic bases of human social and pathological
behavior. Curiously, the OXTR SNP rs53576 is not present on
many currently available chips that are used for genome-wide
association studies of ASD (Meyer-Lindenberg et al., 2011),
limiting their use for such studies.
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In addition, an open challenge is to determine the exact
mechanism by which neuropeptides influence psychiatric
symptoms. Although some reports are shedding light on the
impact of different gene polymorphisms on socially relevant
behaviors and their associated psychiatric disorders, the complete
pathways between genes, gene interactions and behavior is still
a black dark forest. As told by Chomsky, “there’s a famous joke
about a drunk under a lamppost looking for a pencil dropped
on the ground. Somebody comes up and asks ‘What are you
looking for?’ He says, ‘I’m looking for a pencil that I dropped.’
‘Well, where did you drop it?’ He says, ‘Oh, I dropped it across
the street.’ ‘Well, why are looking here?’ ‘This is where there
is light.’ That’s the way the sciences work. [...] If you try to
move it a little further, maybe ultimately you’ll get across the
street.”
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